이엔셀(주)

{
  "address": "서울 송파구",
  "ceo_name": "장종욱",
  "certificate": [
    {
      "cert_number": "20180300467",
      "changes": "",
      "disclosure_date": "2018-06-21",
      "first_cert_date": "2018-06-21",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2018-06-21 ~ 2020-06-20"
    },
    {
      "cert_number": "20200300596",
      "changes": "",
      "disclosure_date": "2020-05-21",
      "first_cert_date": "2018-06-21",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2020-06-21 ~ 2022-06-20"
    },
    {
      "cert_number": "20220609010032",
      "changes": "",
      "disclosure_date": "2022-06-09",
      "first_cert_date": "2018-06-21",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2022-06-21 ~ 2025-06-20"
    },
    {
      "cert_number": "20250729020017",
      "changes": "",
      "disclosure_date": "2025-07-29",
      "first_cert_date": "2018-06-21",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2025-06-21 ~ 2028-06-20"
    }
  ],
  "company_name": "이엔셀 주식회사",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 122394000,
      "cost_of_sales": 6699827000,
      "current_assets": 31644291000,
      "current_liabilities": 74430247000,
      "gross_profit": 667535000,
      "net_income": -45566953000,
      "net_income_bs": -45566953000,
      "non_current_assets": 23102006000,
      "non_current_liabilities": 4151927000,
      "non_operating_expenses": 36815505000,
      "non_operating_income": 563994000,
      "operating_profit": -9315442000,
      "revenue": 7367362000,
      "sga_expenses": 9982977000,
      "total_assets": 54746297000,
      "total_equity": -23835877000,
      "total_liabilities": 78582174000
    },
    "2023": {
      "capital_stock": 4415688000,
      "cost_of_sales": 10883450000,
      "current_assets": 22928326000,
      "current_liabilities": 2742451000,
      "gross_profit": -357563000,
      "net_income": -5053520000,
      "net_income_bs": -5053520000,
      "non_current_assets": 21052825000,
      "non_current_liabilities": 3222368000,
      "non_operating_expenses": 1931753000,
      "non_operating_income": 8633290000,
      "operating_profit": -11755057000,
      "revenue": 10525887000,
      "sga_expenses": 11397494000,
      "total_assets": 43981151000,
      "total_equity": 38016332000,
      "total_liabilities": 5964819000
    },
    "2024": {
      "capital_stock": 5383089000,
      "cost_of_sales": 10194180000,
      "current_assets": 35544729000,
      "current_liabilities": 2688729000,
      "gross_profit": -2984862000,
      "net_income": -15209839000,
      "net_income_bs": -15209839000,
      "non_current_assets": 20200285000,
      "non_current_liabilities": 4888120000,
      "non_operating_expenses": 428198000,
      "non_operating_income": 901469000,
      "operating_profit": -15683110000,
      "revenue": 7209317000,
      "sga_expenses": 12698248000,
      "total_assets": 55745014000,
      "total_equity": 48168165000,
      "total_liabilities": 7576849000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,166,000,000",
      "changes": "2,166,000,000",
      "date": "2021-05-28"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-05-28"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-04-23"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-04-23"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2020-02-14"
    },
    {
      "amount": "666,000,000",
      "changes": "666,000,000",
      "date": "2020-02-14"
    },
    {
      "amount": "666,000,000",
      "changes": "666,000,000",
      "date": "2020-02-14"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2018-05-29"
    }
  ],
  "main_products": "세포유전자치료제",
  "phone": "02-6205-****",
  "years": [
    2024,
    2023,
    2022
  ]
}